CoChat

Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Background: UDP-glucuronosyltransferase 1A1 (UGT1A1) is a pivotal enzyme involved in metabolism of SN-38, the active metabolite of irinotecan commonly used to treat metastatic colorectal cancer. We previously demonstrated aberrant methylation of specific CpG dinucleotides in UGT1A1-negative cells, and revealed that methylation state of the UGT1A1 5'-flanking sequence is negatively correlated with gene transcription. Interestingly, one of these CpG dinucleotides (CpG -4) is found close to a HNF1 response element (HRE), known to be involved in activation of UGT1A1 gene expression, and within an upstream stimulating factor (USF) binding site. Results: Gel retardation assays revealed that methylation of CpG-4 directly affect the interaction of USF1/2 with its cognate sequence without altering the binding for HNF1-alpha. Luciferase assays sustained a role for USF1/2 and HNF1-alpha in UGT1A1 regulation in colon cancer cells. Based on the differential expression profiles of HNF1A gene in colon cell lines, we also assessed whether methylation affects its expression. In agreement with the presence of CpG islands in the HNF1A promoter, treatments of UGT1A1-negative HCT116 colon cancer cells with a DNA methyltransferase inhibitor restore HNF1A gene expression, as observed for UGT1A1. Conclusions: This study reveals that basal UGT1A1 expression in colon cells is positively regulated by HNF1-alpha and USF, and negatively regulated by DNA methylation. Besides, DNA methylation of HNF1A could also play an important role in regulating additional cellular drug metabolism and transporter pathways. This process may contribute to determine local inactivation of drugs such as the anticancer agent SN-38 by glucuronidation and define tumoral response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2199-11-9

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Putative transcription factor binding sites in human UGT1A1 proximal promoter. Schematic representation of the UGT1A1 gene sequence between positions -540 and +10 (relative to the transcription start site). Positions of CpG dinucleotides are shown. Sequences of the putative transcription factor binding sites are boxed. The recognition core sequence for each transcription factor is underlined.
Figure 1 Putative transcription factor binding sites in human UGT1A1 proximal promoter. Schematic representation of the UGT1A1 gene sequence between positions -540 and +10 (relative to the transcription start site). Positions of CpG dinucleotides are shown. Sequences of the putative transcription factor binding sites are boxed. The recognition core sequence for each transcription factor is underlined.CC BY · PubMed Central
Figure 2 Interaction of transcription factors with the UGT1A1 promoter using protein nuclear extracts of UGT1A1-expressing HT29 colon cancer cells. EMSAs were performed with 32P-end-labeled probes. Nuclear protein extracts (5 μg) from HT29 cells were pre-incubated in the presence of either no competitor or 100-fold molar excess of cold competitor oligonucleotides (C) or consensus sequence (Cs). For supershift assays, 2 μg of the indicated antibody (Ab) were added directly after the addition of the labeled probe. For USF assays, Ab1 and Ab2 are directed against USF1 and USF2, respectively.
Figure 2 Interaction of transcription factors with the UGT1A1 promoter using protein nuclear extracts of UGT1A1-expressing HT29 colon cancer cells. EMSAs were performed with 32P-end-labeled probes. Nuclear protein extracts (5 μg) from HT29 cells were pre-incubated in the presence of either no competitor or 100-fold molar excess of cold competitor oligonucleotides (C) or consensus sequence (Cs). For supershift assays, 2 μg of the indicated antibody (Ab) were added directly after the addition of the labeled probe. For USF assays, Ab1 and Ab2 are directed against USF1 and USF2, respectively.CC BY · PubMed Central
Figure 3 Disruption of HNF1-alpha and USF recognition sequences decreases UGT1A1 basal expression in HT29 cells. Mutational analysis of the putative HNF1, OCT1, USF and NF-Y binding sites in the UGT1A1 proximal promoter. Relative luciferase activity is expressed as a fold induction over the promoterless pGL3-basic vector (set to value = 1). Columns, mean of triplicates of three independent experiments; bars, SD; *, P < 0.05
Figure 3 Disruption of HNF1-alpha and USF recognition sequences decreases UGT1A1 basal expression in HT29 cells. Mutational analysis of the putative HNF1, OCT1, USF and NF-Y binding sites in the UGT1A1 proximal promoter. Relative luciferase activity is expressed as a fold induction over the promoterless pGL3-basic vector (set to value = 1). Columns, mean of triplicates of three independent experiments; bars, SD; *, P < 0.05CC BY · PubMed Central
Figure 4 Incubation with in vitro translated USF1 protein demonstrates that methylation of CpG-4 impedes USF1 binding. EMSAs were performed with 32P-end-labeled probes. In vitro translated USF1 proteins were pre-incubated in the presence of either no competitor or 100-fold molar excess of cold competitor oligonucleotides (C) or consensus sequence (Cs). For supershift assay, 2 μg of the indicated antibody (Ab) were added directly after the addition of the labeled probe. Ab1 and Ab2 are directed against USF1 and USF2, respectively. In methylated probes, dC nucleotide is substituted by an internal methyl deoxyCytidine in CpG-4 dinucleotide.
Figure 4 Incubation with in vitro translated USF1 protein demonstrates that methylation of CpG-4 impedes USF1 binding. EMSAs were performed with 32P-end-labeled probes. In vitro translated USF1 proteins were pre-incubated in the presence of either no competitor or 100-fold molar excess of cold competitor oligonucleotides (C) or consensus sequence (Cs). For supershift assay, 2 μg of the indicated antibody (Ab) were added directly after the addition of the labeled probe. Ab1 and Ab2 are directed against USF1 and USF2, respectively. In methylated probes, dC nucleotide is substituted by an internal methyl deoxyCytidine in CpG-4 dinucleotide.CC BY · PubMed Central
Figure 5 Methylation of CpG-4 decreases USF1/2-associated complex stability. EMSAs were performed with 32P-end-labeled probes. Nuclear protein extracts (5 μg) from HT29 cells were pre-incubated in the presence of either no competitor or 10-, 50-, 100-fold molar excess of cold competitors (unmethylated and methylated) or oligonucleotides including either a consensus binding site for HNF1-alpha or USF1/2. In methylated probes, dC nucleotide in CpG dinucleotides is substituted by an internal methyl deoxyCytidine.
Figure 5 Methylation of CpG-4 decreases USF1/2-associated complex stability. EMSAs were performed with 32P-end-labeled probes. Nuclear protein extracts (5 μg) from HT29 cells were pre-incubated in the presence of either no competitor or 10-, 50-, 100-fold molar excess of cold competitors (unmethylated and methylated) or oligonucleotides including either a consensus binding site for HNF1-alpha or USF1/2. In methylated probes, dC nucleotide in CpG dinucleotides is substituted by an internal methyl deoxyCytidine.CC BY · PubMed Central
Figure 6 Upregulation of HNF1A expression is observed following treatment with the 5-Aza-dC demethylating agent in UGT1A1-negative HCT116 colon cancer cells. Rescue of HNF1A gene expression by 5-Aza-dC treatment of colon carcinoma cell lines. Total RNA from HT29 and HCT116 cells were randomly converted to cDNA and specific amplification for USF1, USF2, and HNF1 mRNAs were carried out. Expression of USF1 and USF2 mRNAs are not influenced by 5-Aza-dC treatment. GAPDH gene is used as internal control. Untreated; cells not exposed to 5-Aza-dC.
Figure 6 Upregulation of HNF1A expression is observed following treatment with the 5-Aza-dC demethylating agent in UGT1A1-negative HCT116 colon cancer cells. Rescue of HNF1A gene expression by 5-Aza-dC treatment of colon carcinoma cell lines. Total RNA from HT29 and HCT116 cells were randomly converted to cDNA and specific amplification for USF1, USF2, and HNF1 mRNAs were carried out. Expression of USF1 and USF2 mRNAs are not influenced by 5-Aza-dC treatment. GAPDH gene is used as internal control. Untreated; cells not exposed to 5-Aza-dC.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 86

Metadata

Authors
Bélanger, A.-S., Tojcic, J., Harvey, M., & Guillemette, C.
Affiliations
Centre hospitalier universitaire de Québec (CA)
Corresponding author
Guillemette, Chantal
Venue
BMC Molecular Biology
Published
2010-01-22
Volume
11
Issue
1
Pages
9-9
ISSN
1471-2199 (ISSN-L)
OpenAlex
W2049537372
Cited by
86
References
53
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 6 · 2019: 6 · 2018: 6 · 2017: 2 · 2016: 8 · 2015: 9 · 2014: 9 · 2013: 11 · 2012: 6
FWCI
2.86
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Molecular Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Canadian Institutes of Health Research (MOP-42 392)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords
UGT1A1, DNA methylation, colon cancer, transcriptional regulation, CpG, hypomethylating agents, SN-38, irinotecan, glucuronidation, drug metabolism, HCT116 cells
MeSH terms
UGT1A1 Enzyme, Azacitidine, Base Sequence, Colonic Neoplasms, Cytidine Triphosphate, Humans, Molecular Sequence Data, Promoter Regions, Genetic, Glucuronosyltransferase, Up-Regulation, Gene Expression Regulation, Neoplastic, CpG Islands, HT29 Cells, DNA Methylation, Electrophoretic Mobility Shift Assay, HCT116 Cells, Hepatocyte Nuclear Factor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells. https://app.cochat.ai/papers/10.1186/1471-2199-11-9
The paper
Bélanger, A.-S., Tojcic, J., Harvey, M., & Guillemette, C. (2010). Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells. BMC Molecular Biology. https://doi.org/10.1186/1471-2199-11-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.